Scholarlink

Background <p>Congenital heart defects represent a major global health burden, affecting nearly one million newborns annually. Identifying the underlying genetic causes is essential for improved diagnosis, patient management, and genetic counseling.</p> Patients and methods <p>We conducted a cytogenetic study integrating conventional karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA 44&#xa0;K) in 20 Tunisian patients presenting syndromic CHDs and referred to our Genetics Department.</p> Results and discussion <p>CMA identified pathogenic copy number variations in four patients. These included an inherited 11&#xa0;Mb deletion at 9p24.2 together with a 10&#xa0;Mb duplication of 20pter; a <i>de novo</i> 1.2&#xa0;Mb deletion at 15q26.2 with an 11&#xa0;Mb duplication at 2q36.3; a <i>de novo</i> 113&#xa0;kb deletion at 17q21.32; and a <i>de novo</i> 48&#xa0;Mb duplication at 8q22. Several CNVs overlapped known deletion/duplication syndromes, some with previously infrequent cardiac involvement. Genotype–phenotype correlations enabled prioritization of CHD relevant genes including <i>DOCK8</i>,<i> HTR2B</i>,<i> KANSL1</i>,<i> ZFPM2</i>, and <i>TRPS1</i>, whose dosage sensitivity and interactions with cardiac developmental pathways may contribute to the observed phenotypes.</p> Conclusion <p>This study reinforces the clinical utility of CMA in detecting cryptic chromosomal abnormalities in syndromic CHD. The identified CNVs and gene candidates offer new insights into CHD genetic architecture and support CMA as a first-tier diagnostic tool. These findings highlight the contribution of rare, pathogenic CNVs in syndromic cases and suggest their integration into refined diagnostic and counseling strategies. Further functional studies are necessary to elucidate the roles of these candidates in cardiogenesis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comprehensive analysis of copy number variations in congenital heart defects Tunisian patients: chromosomal microarray analysis insights

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月14日

查看全文
  • Rim Khelifi,
  • Houcemeddine Othmane,
  • Houda Ajmi,
  • Wafa Slimani,
  • Ayda Bennour,
  • Leila Dardour,
  • Najla Soyeh,
  • Amira Benzarti,
  • Khouloud Rjiba,
  • Hamza Hadj Abdallah,
  • Ahmed Rassass,
  • Rim Kooli,
  • Oussama Mghirbi,
  • Molka Kammoun,
  • Hela Ben Khelifa,
  • Farouk Bahri,
  • Mkaddem Hayet,
  • Aouina Ammar,
  • Sahbi Ghanmi,
  • Jihene Mathlouthi,
  • Hayet Ben Hamida,
  • Zakia Habboul,
  • Tarek Kemis,
  • Habib Kharrat,
  • Nadia Hassine,
  • Amel Tej,
  • Manel bellalah,
  • Fatma Chouikh,
  • Mejaouel Houssine,
  • Abdallah Mahdhaoui,
  • Chokri Kortas,
  • Aida Guith,
  • Faouzi Maatouk,
  • Elies Naffeti,
  • Habib Soua,
  • Moez Gribaa,
  • Ali Saad,
  • Soumaya Mougou-Zerelli

摘要

Background

Congenital heart defects represent a major global health burden, affecting nearly one million newborns annually. Identifying the underlying genetic causes is essential for improved diagnosis, patient management, and genetic counseling.

Patients and methods

We conducted a cytogenetic study integrating conventional karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA 44 K) in 20 Tunisian patients presenting syndromic CHDs and referred to our Genetics Department.

Results and discussion

CMA identified pathogenic copy number variations in four patients. These included an inherited 11 Mb deletion at 9p24.2 together with a 10 Mb duplication of 20pter; a de novo 1.2 Mb deletion at 15q26.2 with an 11 Mb duplication at 2q36.3; a de novo 113 kb deletion at 17q21.32; and a de novo 48 Mb duplication at 8q22. Several CNVs overlapped known deletion/duplication syndromes, some with previously infrequent cardiac involvement. Genotype–phenotype correlations enabled prioritization of CHD relevant genes including DOCK8, HTR2B, KANSL1, ZFPM2, and TRPS1, whose dosage sensitivity and interactions with cardiac developmental pathways may contribute to the observed phenotypes.

Conclusion

This study reinforces the clinical utility of CMA in detecting cryptic chromosomal abnormalities in syndromic CHD. The identified CNVs and gene candidates offer new insights into CHD genetic architecture and support CMA as a first-tier diagnostic tool. These findings highlight the contribution of rare, pathogenic CNVs in syndromic cases and suggest their integration into refined diagnostic and counseling strategies. Further functional studies are necessary to elucidate the roles of these candidates in cardiogenesis.